Clinical Trial Update: Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase III confirmatory trial of DE-089 Ophthalmic Solution for dry eye, with results posted in 2014. The sponsor is Sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• DE-089 Ophthalmic Solution

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2014-08-08